Frederick B Oleson, Jr

Title: Innovations in Antibiotic Administration by Frederick B Oleson, Jr.

Introduction

Frederick B Oleson, Jr. is a notable inventor based in Concord, MA (US). He has made significant contributions to the field of antibiotic administration, focusing on minimizing skeletal muscle toxicity while maximizing therapeutic efficacy. With a total of 2 patents, Oleson has developed innovative methods that enhance the safety and effectiveness of antibiotic treatments.

Latest Patents

Oleson's latest patents revolve around methods for administering antibiotics, particularly daptomycin. His inventions provide methods for administering a therapeutically effective amount of daptomycin while minimizing skeletal muscle toxicity. The methods advocate for daptomycin administration at a dosing interval of 24 hours or greater. This extended dosing interval not only minimizes muscle toxicity but also allows for higher peak concentrations of daptomycin, which is crucial for its efficacy. Additionally, Oleson’s patents include methods for administering other lipopeptide antibiotics and quinupristin/dalfopristin, ensuring that these treatments also avoid muscle toxicity through appropriate dosing intervals.

Career Highlights

Frederick B Oleson, Jr. is associated with Cubist Pharmaceuticals, Incorporated, where he has been instrumental in advancing antibiotic therapies. His work has significantly impacted the pharmaceutical industry, particularly in the development of safer antibiotic administration methods.

Collaborations

Oleson collaborates with notable professionals in the field, including his coworker Francis P Tally. Their combined expertise contributes to the innovative approaches in antibiotic treatment.

Conclusion

Frederick B Oleson, Jr. stands out as an inventor dedicated to improving antibiotic administration methods. His work not only enhances the efficacy of treatments but also prioritizes patient safety by minimizing muscle toxicity.